Flexion Therapeutics Inc - Company & Market Research Reports

Flexion Therapeutics is a specialty pharmaceutical company that focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Zilretta, Flexion’s lead investigational product candidate, is an extended release intra-articular, analgesic candidate in late stage development for moderate to severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.

Osteoarthritis Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H2 2017

  • Drug Pipelines
  • 224 Pages
From
Osteoarthritis Pain - Pipeline Review, H1 2017 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H1 2017

  • Drug Pipelines
  • 202 Pages
From
From
From
Osteoarthritis - Pipeline Review, H2 2018 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 274 Pages
From
Osteoarthritis - Pipeline Review, H1 2018 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 240 Pages
From
From
From
From
From
From
From
From
Flexion Therapeutics Inc - Product Thumbnail Image

Flexion Therapeutics Inc

  • Company Profile
  • 74 Pages
Loading Indicator
adroll